Cubist Systematic Strategies, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $363,629 - $500,754	13,879 Added 27.71%	63,964 $1.72 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $1.26 Million - $2.07 Million	50,085 New	50,085 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $876,988 - $1.27 Million	31,321 Added 135.81%	54,384 $2.21 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $1.02 Million - $1.66 Million	-34,317 Reduced 59.81%	23,063 $762,000
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $1.5 Million - $2.73 Million	-53,923 Reduced 48.45%	57,380 $2.02 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $3.43 Million - $6.06 Million	86,594 Added 350.46%	111,303 $5.12 Million
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $1.06 Million - $1.5 Million	18,220 Added 280.78%	24,709 $1.64 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $3.34 Million - $4.86 Million	-57,214 Reduced 89.81%	6,489 $405,000
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $1.47 Million - $2.13 Million	23,611 Added 58.89%	63,703 $5.28 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $2.12 Million - $3.12 Million	34,521 Added 619.66%	40,092 $2.66 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $317,037 - $617,651	-7,235 Reduced 56.5%	5,571 $427,000
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $154,492 - $238,508	4,652 Added 57.05%	12,806 $551,000
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $260,259 - $431,142	-9,964 Reduced 55.0%	8,154 $352,000
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $487,909 - $1.5 Million	-23,731 Reduced 56.71%	18,118 $521,000
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $240,400 - $623,724	8,543 Added 25.65%	41,849 $2.65 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $387,492 - $514,394	-14,756 Reduced 30.7%	33,306 $939,000
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $574,457 - $949,849	32,958 Added 218.21%	48,062 $1.27 Million
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $50,429 - $84,453	-4,185 Reduced 21.7%	15,104 $277,000
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $207,163 - $379,993	19,289 New	19,289 $240,000
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $251,174 - $364,202	-17,941 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $114,284 - $251,532	17,941 New	17,941 $244,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account